Medpace Holdings Inc (MEDP)
307.50
-3.13
(-1.01%)
USD |
NASDAQ |
Nov 18, 12:53
Medpace Holdings Profit Margin (Quarterly): 18.08% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.08% |
| June 30, 2024 | 16.73% |
| March 31, 2024 | 20.07% |
| December 31, 2023 | 15.71% |
| September 30, 2023 | 14.32% |
| June 30, 2023 | 13.25% |
| March 31, 2023 | 16.79% |
| December 31, 2022 | 17.42% |
| September 30, 2022 | 17.21% |
| June 30, 2022 | 14.05% |
| March 31, 2022 | 18.53% |
| December 31, 2021 | 16.22% |
| September 30, 2021 | 16.43% |
| June 30, 2021 | 14.35% |
| March 31, 2021 | 16.66% |
| December 31, 2020 | 19.59% |
| September 30, 2020 | 18.00% |
| June 30, 2020 | 11.76% |
| March 31, 2020 | 12.54% |
| December 31, 2019 | 12.97% |
| Date | Value |
|---|---|
| September 30, 2019 | 11.09% |
| June 30, 2019 | 12.82% |
| March 31, 2019 | 9.56% |
| December 31, 2018 | 11.85% |
| September 30, 2018 | 10.77% |
| June 30, 2018 | 9.74% |
| March 31, 2018 | 8.92% |
| December 31, 2017 | 10.02% |
| September 30, 2017 | 8.89% |
| June 30, 2017 | 8.99% |
| March 31, 2017 | 7.92% |
| December 31, 2016 | -0.02% |
| September 30, 2016 | 4.67% |
| June 30, 2016 | 4.68% |
| March 31, 2016 | 3.46% |
| December 31, 2015 | -8.93% |
| September 30, 2015 | -0.14% |
| June 30, 2015 | 0.11% |
| March 31, 2015 | -0.07% |
| March 31, 2014 | -1.59% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
11.76%
Minimum
Jun 2020
20.07%
Maximum
Mar 2024
16.03%
Average
16.55%
Median
Profit Margin (Quarterly) Benchmarks
| Globus Medical Inc | 8.28% |
| IQVIA Holdings Inc | 7.32% |
| Fortrea Holdings Inc | -4.13% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 54.64% |
| Return on Assets | 20.44% |
| Return on Invested Capital | 54.64% |
| Gross Profit Margin (Quarterly) | 31.69% |
| Operating Margin (Quarterly) | 21.05% |
| Return on Net Operating Assets | 29.18% |